Eli Lilly and Company (LLY) vs Tokio Marine Holdings, Inc. (TKOMY)
See how Eli Lilly and Company and Tokio Marine Holdings, Inc. differ across market data and performance, so you can decide which asset best fits your strategy.
$1,163.23
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page$50.5
OTC Markets OTCPK
Key Metrics Comparison
Eli Lilly and CompanyLLY
Market Cap$1.037T
Price$1,163.23
24h Change+1.76%
24h Volume$945.7K
Employees50,000
Shares Outstanding944,818,881
Tokio Marine Holdings, Inc.TKOMY
Market Cap$1.431T
Price$50.5
24h Change+1.84%
24h Volume$54.3K
Employees67,526
Shares OutstandingN/A
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
LLY
42.0%TKOMY
58.0%Volume Share
Share of combined 24h volume
LLY
94.6%TKOMY
5.4%24h Performance
Price change over last 24 hours
LLY
1.76%TKOMY
1.84%Price Comparison
Eli Lilly and Company
Tokio Marine Holdings, Inc.